CD8A and neoplasm: The FACS analyses of tumor‐infiltrating leukocytes show that thymol treatment significantly increases the proportion of CD8+ T cells, especially GZMB+ CD8+ T cells, and decreases the proportion of Tregs and M2‐like macrophages (Figure 6E,F and Figure S7).